关于VEGFR抑制剂的进展:对新型抗癌剂的全面审查
Sumeet Jha1, Sneha Gupta1, Supriya Rani1
1School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road, Phagwara, Punjab, 144411, India.
Anti-cancer agents in medicinal chemistry
|January 15, 2025
概括
新的VEGFR抑制剂在阻断瘤血液供应和扩散方面表现有前途. 本综述强调了药物化学的进步和开发这些向癌症治疗的挑战.
科学领域:
- 在瘤学瘤学.
- 药用化学 医学化学
- 分子生物学分子生物学
背景情况:
- 癌症是全球领先的健康挑战,由不受控制的细胞生长驱动.
- 瘤血管生成由血管内皮生长因子受体 (VEGFR) 促进,支持瘤生长和转移.
- VEGFR抑制剂向VEGF-VEGFR通路,以阻止瘤血管化和扩散.
研究的目的:
- 审查血管内皮生长因子受体 (VEGFR) 抑制剂的最新药物化学进展.
- 评估各种癌症细胞系中新型VEGFR抑制剂的疗效.
- 突出在开发有效的VEGFR向癌症疗法方面面临的挑战和未来方向.
主要方法:
- 关于VEGFR抑制剂及其化学成分的当前文献的综述.
- 来自体外,体内和体外研究的疗效数据的分析.
- 包括用于结合亲和力,药理动力学和药物相似性预测的计算分析.
主要成果:
- 几种新型化合物通过向的VEGFR激酶抑制显示出显著的抗癌潜力.
- 研究证实了这些化合物的抗瘤作用,阻碍了血管生成和转移.
- 计算研究支持有希望的抑制剂的药物相似性和药理动力学特征.
结论:
- VEGFR抑制剂通过破坏瘤血管生成来代表癌症治疗的战略方法.
- 最近药物化学的努力已经产生了有前途的新型化合物,具有已证明的抗瘤活性.
- 需要进一步的研究来克服挑战并优化VEGFR抑制剂,以提高癌症治疗的疗效.
更多相关视频
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
13.6K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
17.8K
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
01:24Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
01:30Cancer Vaccines
336
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
336
01:27Tumor Immunotherapy
469
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
469